Largan Precision (3008) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
First quarter net revenue reached NT$14.58 billion, up 29% year-over-year from NT$11.31 billion in Q1 2023, but down 20% sequentially from the previous quarter.
Net income for 1Q25 was NT$6.44 billion, a 5% increase year-over-year but a 26% decrease sequentially.
Gross margin improved to 55% from 49% in the prior year period.
Operating income rose 54% year-over-year to NT$6.09 billion, but fell 27% from the previous quarter.
Basic EPS for Q1 2024 was NT$48.28, compared to NT$45.79 in Q1 2023 and NT$65.01 in 4Q24.
Financial highlights
Gross profit for 1Q25 was NT$7.96 billion, up 43% year-over-year and down 26% sequentially.
Operating expenses increased to NT$1,878 million, up from NT$1,602 million year-over-year.
Interest income for the quarter was NT$1,137 million, slightly up from NT$1,097 million last year.
Cash and cash equivalents at quarter-end were NT$121,892 million, up from NT$114,674 million a year ago.
Consolidated sales for the quarter totaled NT$14.58 billion, a 29% year-over-year increase.
Segment performance
10MP lens shipments accounted for 60-70% of total shipments in 1Q25.
20MP+ lenses made up 20-30% of shipments, while 8MP and others comprised the remaining 10-20%.
Latest events from Largan Precision
- Q2 2023/2Q24 saw strong revenue and net income growth, with EPS reaching NT$79.49.3008
Q2 20249 Jul 2026 - Net income rose 45% on up to 24% revenue growth, with gross margin at 52% and strong cash reserves.3008
Q4 20249 Jul 2026 - Q3 revenue rose 39% to NT$18.95bn, net income hit NT$6.63bn, and gross margin reached 50%.3008
Q3 20249 Jul 2026 - 3Q25 saw strong revenue and margin gains, but nine-month net income declined year-over-year.3008
Q3 20259 Jul 2026 - 2Q25 revenue up 6.3%, but net income and EPS fell sharply due to FX losses.3008
Q2 20259 Jul 2026 - Revenue up 7% but net profit down 6% in Q1 2026 amid margin pressure and legal risks.3008
Q1 20269 Jul 2026 - Revenue and net income surged year-over-year, driven by robust lens shipments and margin strength.3008
Q2 20269 Jul 2026 - 2025 saw higher revenue but lower net income, with major investments and treasury share buybacks.3008
Q4 202526 May 2026